Publication | Open Access

Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma

Hematological MalignancyLymphoid NeoplasiaElderly PatientsMedicineStandard ChemotherapyHematologyPathologyMetronomic ChemotherapyPoor Treatment ToleranceOncologyCancer Research